Skip to main content
. 2021 Sep 18;13(9):1514. doi: 10.3390/pharmaceutics13091514

Table 2.

Number of available subjects for analysis for the 8 models.

Model Cohort 1 Cohort 2 Total
A 1318 2540 3858
B 170 3688 3858
C 1318 393,142 394,460
D 170 393,142 393,312
E 3858 393,142 397,000
F 3858 26,977 30,835
G 1318 26,977 28,295
H 170 26,977 27,147

Only subjects with available GP prescription records are shown.